Chemed Corporation $CHE Shares Sold by Horizon Investments LLC

Horizon Investments LLC lowered its position in Chemed Corporation (NYSE:CHE) by 88.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 206 shares of the company’s stock after selling 1,607 shares during the quarter. Horizon Investments LLC’s holdings in Chemed were worth $88,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its position in shares of Chemed by 122.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock worth $223,856,000 after purchasing an additional 275,423 shares during the last quarter. AQR Capital Management LLC increased its position in shares of Chemed by 160.9% in the 2nd quarter. AQR Capital Management LLC now owns 201,041 shares of the company’s stock worth $97,893,000 after purchasing an additional 123,982 shares during the last quarter. M&T Bank Corp increased its position in shares of Chemed by 10,291.1% in the 4th quarter. M&T Bank Corp now owns 85,934 shares of the company’s stock worth $36,768,000 after purchasing an additional 85,107 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Chemed by 740.9% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 95,573 shares of the company’s stock worth $42,792,000 after purchasing an additional 84,208 shares during the last quarter. Finally, Epoch Investment Partners Inc. increased its position in shares of Chemed by 29.4% in the 3rd quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock worth $137,579,000 after purchasing an additional 69,878 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer directly owned 90,219 shares in the company, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 3.33% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Oppenheimer dropped their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Royal Bank Of Canada boosted their target price on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Wall Street Zen raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Two equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $501.50.

Chemed Price Performance

NYSE CHE opened at $424.48 on Monday. The company has a 50-day moving average price of $396.39 and a two-hundred day moving average price of $425.74. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The stock has a market cap of $5.63 billion, a price-to-earnings ratio of 23.13, a price-to-earnings-growth ratio of 1.59 and a beta of 0.54. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $583.96.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business’s revenue was up 1.6% on a year-over-year basis. During the same period last year, the firm posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were issued a $0.60 dividend. The ex-dividend date was Monday, February 23rd. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is 13.08%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.